Mata, E., Broset, E., Matute, C, Adame S, Alejo T, Lopez A, Andres B, Heredero J, de Miguel D, Giménez-Warren J, Lampaya V, Diego Casabona D, Calvo A, Quincoces G, Iván Peñuelas I, Gamazo C, Uranga I, Peña N, Arias M, Pardo J, Moreno B, Badiola J, Martínez-Oliván J & Pérez-Herrán E. Preserved efficacy of lyophilized SARS-CoV-2 mRNA vaccine incorporating novel ionizable lipids after one year at 25 °C. npj Vaccines 10, 135 (2025). https://doi.org/10.1038/s41541-025-01201-1.

Compartir